nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Vinblastine—head and neck cancer	0.157	0.343	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—head and neck cancer	0.129	0.283	CbGbCtD
Tolvaptan—CYP3A4—Vinblastine—head and neck cancer	0.0941	0.205	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—head and neck cancer	0.0776	0.169	CbGbCtD
Tolvaptan—Colitis ischaemic—Docetaxel—head and neck cancer	0.026	0.0512	CcSEcCtD
Tolvaptan—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0214	0.0421	CcSEcCtD
Tolvaptan—Rash generalised—Docetaxel—head and neck cancer	0.018	0.0354	CcSEcCtD
Tolvaptan—Prurigo—Docetaxel—head and neck cancer	0.0166	0.0326	CcSEcCtD
Tolvaptan—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.0159	0.0312	CcSEcCtD
Tolvaptan—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.015	0.0295	CcSEcCtD
Tolvaptan—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0126	0.0247	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Vinblastine—head and neck cancer	0.012	0.0235	CcSEcCtD
Tolvaptan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.01	0.0197	CcSEcCtD
Tolvaptan—Breast disorder—Hydroxyurea—head and neck cancer	0.00966	0.019	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00809	0.0159	CcSEcCtD
Tolvaptan—Respiratory failure—Docetaxel—head and neck cancer	0.00779	0.0153	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00769	0.0151	CcSEcCtD
Tolvaptan—Pulmonary embolism—Docetaxel—head and neck cancer	0.00765	0.015	CcSEcCtD
Tolvaptan—Angiopathy—Hydroxyurea—head and neck cancer	0.00671	0.0132	CcSEcCtD
Tolvaptan—Ill-defined disorder—Vinblastine—head and neck cancer	0.00655	0.0129	CcSEcCtD
Tolvaptan—Malaise—Vinblastine—head and neck cancer	0.00636	0.0125	CcSEcCtD
Tolvaptan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00597	0.0117	CcSEcCtD
Tolvaptan—Discomfort—Vinblastine—head and neck cancer	0.00594	0.0117	CcSEcCtD
Tolvaptan—Renal impairment—Docetaxel—head and neck cancer	0.00583	0.0115	CcSEcCtD
Tolvaptan—Malaise—Hydroxyurea—head and neck cancer	0.0058	0.0114	CcSEcCtD
Tolvaptan—Hyponatraemia—Docetaxel—head and neck cancer	0.00557	0.011	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00555	0.0109	CcSEcCtD
Tolvaptan—Anorexia—Vinblastine—head and neck cancer	0.00549	0.0108	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00544	0.0107	CcSEcCtD
Tolvaptan—Discomfort—Hydroxyurea—head and neck cancer	0.00541	0.0106	CcSEcCtD
Tolvaptan—Dehydration—Docetaxel—head and neck cancer	0.00516	0.0102	CcSEcCtD
Tolvaptan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00515	0.0101	CcSEcCtD
Tolvaptan—Skin disorder—Hydroxyurea—head and neck cancer	0.0051	0.01	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00507	0.00997	CcSEcCtD
Tolvaptan—Breast disorder—Docetaxel—head and neck cancer	0.00502	0.00987	CcSEcCtD
Tolvaptan—Anorexia—Hydroxyurea—head and neck cancer	0.00501	0.00985	CcSEcCtD
Tolvaptan—Decreased appetite—Vinblastine—head and neck cancer	0.00501	0.00985	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.005	0.00983	CcSEcCtD
Tolvaptan—Constipation—Vinblastine—head and neck cancer	0.00493	0.00969	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0049	0.00963	CcSEcCtD
Tolvaptan—Feeling abnormal—Vinblastine—head and neck cancer	0.00475	0.00933	CcSEcCtD
Tolvaptan—Decreased appetite—Hydroxyurea—head and neck cancer	0.00457	0.00898	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00453	0.00892	CcSEcCtD
Tolvaptan—Constipation—Hydroxyurea—head and neck cancer	0.00449	0.00883	CcSEcCtD
Tolvaptan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00433	0.00851	CcSEcCtD
Tolvaptan—Hypersensitivity—Vinblastine—head and neck cancer	0.00424	0.00834	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—head and neck cancer	0.00421	0.00827	CcSEcCtD
Tolvaptan—Body temperature increased—Hydroxyurea—head and neck cancer	0.00415	0.00817	CcSEcCtD
Tolvaptan—Asthenia—Vinblastine—head and neck cancer	0.00413	0.00813	CcSEcCtD
Tolvaptan—Diarrhoea—Vinblastine—head and neck cancer	0.00394	0.00775	CcSEcCtD
Tolvaptan—Discomfort—Fluorouracil—head and neck cancer	0.0039	0.00766	CcSEcCtD
Tolvaptan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00387	0.00761	CcSEcCtD
Tolvaptan—Dizziness—Vinblastine—head and neck cancer	0.00381	0.00749	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—head and neck cancer	0.00379	0.00746	CcSEcCtD
Tolvaptan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00378	0.00744	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—head and neck cancer	0.00377	0.00742	CcSEcCtD
Tolvaptan—Asthenia—Hydroxyurea—head and neck cancer	0.00377	0.00741	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—head and neck cancer	0.00376	0.0074	CcSEcCtD
Tolvaptan—Nervous system disorder—Fluorouracil—head and neck cancer	0.00371	0.00729	CcSEcCtD
Tolvaptan—Headache—Vinblastine—head and neck cancer	0.00361	0.0071	CcSEcCtD
Tolvaptan—Anorexia—Fluorouracil—head and neck cancer	0.0036	0.00709	CcSEcCtD
Tolvaptan—Diarrhoea—Hydroxyurea—head and neck cancer	0.00359	0.00707	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—head and neck cancer	0.00356	0.00701	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—head and neck cancer	0.00348	0.00685	CcSEcCtD
Tolvaptan—Dizziness—Hydroxyurea—head and neck cancer	0.00347	0.00683	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—head and neck cancer	0.00347	0.00682	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—head and neck cancer	0.00346	0.00681	CcSEcCtD
Tolvaptan—Nausea—Vinblastine—head and neck cancer	0.00342	0.00673	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—head and neck cancer	0.00334	0.00658	CcSEcCtD
Tolvaptan—Headache—Hydroxyurea—head and neck cancer	0.00329	0.00647	CcSEcCtD
Tolvaptan—Decreased appetite—Fluorouracil—head and neck cancer	0.00329	0.00646	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—head and neck cancer	0.00327	0.00644	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00326	0.00642	CcSEcCtD
Tolvaptan—Nausea—Hydroxyurea—head and neck cancer	0.00312	0.00614	CcSEcCtD
Tolvaptan—Feeling abnormal—Fluorouracil—head and neck cancer	0.00312	0.00613	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—head and neck cancer	0.003	0.0059	CcSEcCtD
Tolvaptan—Body temperature increased—Fluorouracil—head and neck cancer	0.00299	0.00588	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—head and neck cancer	0.00294	0.00578	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00283	0.00556	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluorouracil—head and neck cancer	0.00279	0.00548	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—head and neck cancer	0.00278	0.00547	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—head and neck cancer	0.00273	0.00537	CcSEcCtD
Tolvaptan—Shock—Docetaxel—head and neck cancer	0.00268	0.00528	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—head and neck cancer	0.00268	0.00526	CcSEcCtD
Tolvaptan—Pruritus—Fluorouracil—head and neck cancer	0.00267	0.00526	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—head and neck cancer	0.00265	0.00521	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—head and neck cancer	0.0026	0.00512	CcSEcCtD
Tolvaptan—Diarrhoea—Fluorouracil—head and neck cancer	0.00259	0.00509	CcSEcCtD
Tolvaptan—Dizziness—Fluorouracil—head and neck cancer	0.0025	0.00492	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—head and neck cancer	0.00237	0.00466	CcSEcCtD
Tolvaptan—Headache—Fluorouracil—head and neck cancer	0.00237	0.00466	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00236	0.00463	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—head and neck cancer	0.00233	0.00459	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—head and neck cancer	0.00225	0.00442	CcSEcCtD
Tolvaptan—Nausea—Fluorouracil—head and neck cancer	0.00225	0.00442	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—head and neck cancer	0.00216	0.00424	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—head and neck cancer	0.00201	0.00395	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—head and neck cancer	0.00196	0.00385	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—head and neck cancer	0.00193	0.0038	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—head and neck cancer	0.00187	0.00367	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—head and neck cancer	0.0018	0.00355	CcSEcCtD
Tolvaptan—Headache—Docetaxel—head and neck cancer	0.00171	0.00336	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—head and neck cancer	0.00162	0.00319	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—KISS1—head and neck cancer	0.00138	0.0414	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.00136	0.0409	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.00135	0.0406	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00123	0.0371	CbGpPWpGaD
Tolvaptan—AVPR2—Arf6 trafficking events—CDH1—head and neck cancer	0.00119	0.0356	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—GRP—head and neck cancer	0.00114	0.0341	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00112	0.0337	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00111	0.0335	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00102	0.0305	CbGpPWpGaD
Tolvaptan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000934	0.0281	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000913	0.0274	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000906	0.0273	CbGpPWpGaD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000793	0.0238	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000752	0.0226	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000746	0.0224	CbGpPWpGaD
Tolvaptan—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000724	0.0218	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—KISS1—head and neck cancer	0.000695	0.0209	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—KISS1—head and neck cancer	0.00069	0.0208	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000575	0.0173	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—GRP—head and neck cancer	0.000572	0.0172	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—GRP—head and neck cancer	0.000568	0.0171	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000488	0.0147	CbGpPWpGaD
Tolvaptan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000457	0.0137	CbGpPWpGaD
Tolvaptan—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000439	0.0132	CbGpPWpGaD
Tolvaptan—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000416	0.0125	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—KISS1—head and neck cancer	0.000393	0.0118	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—KISS1—head and neck cancer	0.00039	0.0117	CbGpPWpGaD
Tolvaptan—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000382	0.0115	CbGpPWpGaD
Tolvaptan—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000368	0.0111	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KISS1—head and neck cancer	0.000357	0.0107	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KISS1—head and neck cancer	0.000354	0.0106	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—GRP—head and neck cancer	0.000324	0.00973	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—GRP—head and neck cancer	0.000321	0.00966	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—GRP—head and neck cancer	0.000294	0.00883	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—GRP—head and neck cancer	0.000292	0.00877	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000217	0.00654	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KISS1—head and neck cancer	0.000211	0.00634	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KISS1—head and neck cancer	0.000209	0.00629	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000207	0.00622	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000207	0.00622	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000201	0.00604	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000199	0.00599	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000196	0.0059	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000181	0.00545	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00018	0.0054	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—GRP—head and neck cancer	0.000174	0.00522	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—GRP—head and neck cancer	0.000172	0.00518	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT6—head and neck cancer	0.000168	0.00507	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT6—head and neck cancer	0.000167	0.00503	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000166	0.005	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000159	0.00477	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000157	0.00471	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000151	0.00454	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—YAP1—head and neck cancer	0.000149	0.00448	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—YAP1—head and neck cancer	0.000148	0.00445	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000146	0.00439	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000144	0.00433	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000129	0.00387	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000114	0.00343	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000112	0.00336	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000109	0.00329	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000109	0.00327	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UROD—head and neck cancer	9.76e-05	0.00293	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	9.69e-05	0.00291	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—IL2—head and neck cancer	8.62e-05	0.00259	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—IL2—head and neck cancer	8.56e-05	0.00257	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL2—head and neck cancer	7.83e-05	0.00235	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL2—head and neck cancer	7.77e-05	0.00234	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	7.44e-05	0.00224	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.21e-05	0.00217	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.14e-05	0.00215	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.11e-05	0.00214	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	6.84e-05	0.00206	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.74e-05	0.00203	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOTCH1—head and neck cancer	6.72e-05	0.00202	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOTCH1—head and neck cancer	6.67e-05	0.00201	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.39e-05	0.00192	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—head and neck cancer	6.29e-05	0.00189	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—head and neck cancer	6.25e-05	0.00188	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.07e-05	0.00182	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UROD—head and neck cancer	6.01e-05	0.00181	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK1—head and neck cancer	5.99e-05	0.0018	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—head and neck cancer	5.99e-05	0.0018	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK1—head and neck cancer	5.95e-05	0.00179	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—head and neck cancer	5.94e-05	0.00179	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.72e-05	0.00172	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—head and neck cancer	5.68e-05	0.00171	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.48e-05	0.00165	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.29e-05	0.00159	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—head and neck cancer	5.2e-05	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—head and neck cancer	5.16e-05	0.00155	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—head and neck cancer	4.81e-05	0.00145	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.78e-05	0.00144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—head and neck cancer	4.77e-05	0.00144	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—head and neck cancer	4.67e-05	0.00141	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—head and neck cancer	4.64e-05	0.0014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL2—head and neck cancer	4.62e-05	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL2—head and neck cancer	4.59e-05	0.00138	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.52e-05	0.00136	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—head and neck cancer	4.51e-05	0.00136	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—head and neck cancer	4.48e-05	0.00135	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTEN—head and neck cancer	4.35e-05	0.00131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTEN—head and neck cancer	4.32e-05	0.0013	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.3e-05	0.00129	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.3e-05	0.00129	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—head and neck cancer	4.24e-05	0.00128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—head and neck cancer	4.21e-05	0.00127	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAT2—head and neck cancer	4.05e-05	0.00122	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—head and neck cancer	3.93e-05	0.00118	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—head and neck cancer	3.9e-05	0.00117	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—head and neck cancer	3.89e-05	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—head and neck cancer	3.86e-05	0.00116	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.73e-05	0.00112	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—head and neck cancer	3.72e-05	0.00112	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—head and neck cancer	3.69e-05	0.00111	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.61e-05	0.00109	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DPYD—head and neck cancer	3.55e-05	0.00107	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK1—head and neck cancer	3.54e-05	0.00106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—head and neck cancer	3.54e-05	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK1—head and neck cancer	3.51e-05	0.00106	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—head and neck cancer	3.51e-05	0.00106	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—YAP1—head and neck cancer	3.37e-05	0.00101	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—head and neck cancer	3.07e-05	0.000923	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.05e-05	0.000917	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—head and neck cancer	3.05e-05	0.000916	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—head and neck cancer	2.97e-05	0.000893	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—head and neck cancer	2.95e-05	0.000886	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—head and neck cancer	2.84e-05	0.000854	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—head and neck cancer	2.82e-05	0.000848	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—head and neck cancer	2.51e-05	0.000754	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAT2—head and neck cancer	2.5e-05	0.000751	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—head and neck cancer	2.49e-05	0.000749	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DPYD—head and neck cancer	2.19e-05	0.000658	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—YAP1—head and neck cancer	2.08e-05	0.000625	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMS—head and neck cancer	2.03e-05	0.000609	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—head and neck cancer	2e-05	0.000602	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—head and neck cancer	1.92e-05	0.000576	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.9e-05	0.000571	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMS—head and neck cancer	1.25e-05	0.000375	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.23e-05	0.000371	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—head and neck cancer	1.18e-05	0.000355	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.17e-05	0.000352	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—head and neck cancer	1.13e-05	0.000339	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTEN—head and neck cancer	9.84e-06	0.000296	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.95e-06	0.000209	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.94e-06	0.000209	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTEN—head and neck cancer	6.06e-06	0.000182	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—head and neck cancer	5.67e-06	0.000171	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.28e-06	0.000129	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—head and neck cancer	3.49e-06	0.000105	CbGpPWpGaD
